NCT06803732 Postoperative Pain of Robotic, Endoscopic and Open Lateral Neck Dissection
| NCT ID | NCT06803732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai 6th People's Hospital |
| Condition | Pain, Postoperative |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2024-11-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postoperative pain is a good indicator to confirm the advantages of the surgical methods in the era of minimally invasive surgery. Lateral neck dissection requires extensive dissection which may leads to postoperative numbness and pain. Robotic thyroid surgery has the advantage of precise and careful dissection and avoid the L-shape incision in the open approach. The study aims to explore the pain intensity and severity of lateral neck dissection on operation day, postoperative month 1 and postoperative month 3 among the robotic, endoscopic and open approach.
Eligibility Criteria
Inclusion Criteria: * Patients underwent lateral neck dissection via robotic, endoscopic or open approach * Clinical diagnosis of differentiated thyroid cancer * Clinical diagnosis of metastatic lateral lymph nodes Exclusion Criteria: * Participants with distant metastasis * Participants with history of neck surgery or radiation * Participants with vocal fold fixation by preoperative fibrolaryngoscope
Contact & Investigator
Ling Zhan, Dr
PRINCIPAL INVESTIGATOR
Shanghai 6th People's Hospital
Frequently Asked Questions
Who can join the NCT06803732 clinical trial?
This trial is open to participants of all sexes, studying Pain, Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06803732 currently recruiting?
Yes, NCT06803732 is actively recruiting participants. Contact the research team at 15821120972@163.com for enrollment information.
Where is the NCT06803732 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06803732 clinical trial?
NCT06803732 is sponsored by Shanghai 6th People's Hospital. The principal investigator is Ling Zhan, Dr at Shanghai 6th People's Hospital. The trial plans to enroll 600 participants.